用信息价值评估个性化标签收益,避免无效标注浪费资源。
HB-PVI: A Hierarchical Bayesian Personalization and Value-of-Information Framework for Complex Activity Recognition

- 构建分层贝叶斯框架,同时建模个体差异与标签成本效益。
- 在47人数据集上,零额外标签即可保持0.00217的准确率损失。
- 适合医疗传感中标签昂贵、个性化收益有限的场景。
个性化可提升活动识别性能,但个体增益异质,且每新增一个标注标签都有成本。本文提出HB-PVI框架,联合建模参与者异质性、四种个性化机制的利弊以及额外标签的经济价值,基于47人的MUSIC-CAR复杂活动数据集。采用安全去泄露的留一参与者外评估,结合序贯蒙特卡洛参与者效应更新器、学生-t分层增益模型和一步期望样本信息价值(EVSI)停止规则。适配器个性化带来微小正向平均F1提升,从1个标签时的0.00099增至10个时的0.00198;而适配器+头部及原型残差个性化平均为负。在主要实用效益阈值(Δ_min=0.01)和成本设定下,所有决策状态下一步EVSI为零,策略未购买任何标签,始终保留群体推断,与永远不停完全一致(实际等价区域概率=1)。相比固定十次提示适配器个性化,该方法减少100%标注量,同时保持后验均值F1损失为0.00217(95%可信区间:0.00048至0.00389),后验概率0.9992低于0.005容差。在216种成本-阈值组合中,有199种下HB-PVI为效用最优,所有高于主标签成本的设置下均为最优。结果表明,当个性化增益相对于标注、计算与潜在伤害成本较小时,应优先采用群体先部署策略,强调信息价值而非预测精度来指导健康感知中的个性化决策。
原文摘要 · Abstract (English)
Personalization can improve activity-recognition performance, but participant-specific gains are heterogeneous, and every additional calibration label has an acquisition cost. This study presents HB-PVI, a hierarchical Bayesian personalization and value-of-information framework jointly modeling participant heterogeneity, the benefit and harm of four personalization mechanisms, and the economic value of an additional label, for the 47-participant MUSIC-CAR complex-activity cohort. A leakage-safe, leave-one-participant-out evaluation combines a sequential-Monte-Carlo participant-effect updater with a Student-$t$ hierarchical gain model and a one-step expected-value-of-sample-information (EVSI) stopping rule. Adapter personalization produced small positive mean F1 gains, growing from 0.00099 at one label to 0.00198 at ten, while adapter-plus-head and prototype-residual personalization were negative on average. Under the primary practical-benefit threshold ($\Delta_{\min}=0.01$) and cost setting, one-step EVSI was zero at every decision state, so the policy purchased no labels and retained population inference for all 47 participants, matching always-stop exactly (region-of-practical-equivalence probability $=1$). Relative to fixed ten-shot adapter personalization, this reduced labeling by 100\% while keeping the posterior mean F1 loss at 0.00217 (95\% credible interval, 0.00048 to 0.00389), with posterior probability 0.9992 of remaining below the 0.005 tolerance. HB-PVI was utility-optimal in 199 of 216 cost-threshold settings and in every setting at or above the primary label cost. These results argue for a population-first deployment policy whenever personalization gains are small relative to labeling, computation, and harm costs, and show that value-of-information reasoning, not raw predictive accuracy, should drive personalization decisions in health-sensing applications.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。